Vivanza Biosciences Board Meeting Rescheduled to May 7, 2026

Vivanza Biosciences Ltd has rescheduled its Board of Directors meeting to May 7, 2026, from the previously scheduled date of May 4, 2026, due to unavoidable circumstances. The meeting will consider and approve the audited standalone and consolidated financial results along with the Audit Report of the Company for the quarter and year ended March 31, 2026. The trading window, previously intimated, will remain closed until 48 hours after the declaration of the results.